Sulforaphane attenuation of type 2 diabetes-induced aortic damage was associated with the upregulation of Nrf2 expression and function

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Wang, Yonggang ^a,b   Zhang, Zhiguo ^a,b   Sun, Wanqing ^a   Tan, Yi ^b,c   Liu, Yucheng ^b   Zheng, Yang ^a   Liu, Quan ^a   Cai, Lu ^b,c   Sun, Jian ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b University of Louisville School of Medicine   (United States)

^c WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CELL PROLIFERATION; CHEMICAL COMPOUNDS; COLLAGEN; GENE EXPRESSION; MAMMALS; MUSCULOSKELETAL SYSTEM;

4-HYDROXY-2-NONENAL; CONNECTIVE TISSUE GROWTH FACTOR; PATHOLOGICAL CHANGES; TRANSFORMING GROWTH FACTORS; TUMOR NECROSIS FACTORS; TYPE 2 DIABETES MELLITUS; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR COMPLICATIONS;

BLOOD VESSELS;

3 NITROTYROSINE; 4 HYDROXYNONENAL; CONNECTIVE TISSUE GROWTH FACTOR; STREPTOZOCIN; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ISOTHIOCYANIC ACID DERIVATIVE; PROTECTIVE AGENT; SULFORAFAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA DISEASE; APOPTOSIS; ARTICLE; BLOOD VESSEL WALL; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FIBROSIS; HEART PROTECTION; INFLAMMATION; LIPID DIET; MALE; MOUSE; NITRATIVE STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TYPE 2 DIABETES INDUCED AORTIC DAMAGE; UPREGULATION; ANIMAL; AORTA; C57BL MOUSE; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; AORTA; APOPTOSIS; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; FIBROSIS; INFLAMMATION; ISOTHIOCYANATES; MALE; MICE; MICE, INBRED C57BL; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PROTECTIVE AGENTS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84897004164     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/123963     Document Type: Article

References (44)

1. Atlas I. D., The Global Burden 2009 4th Brussels, Belgium International Diabetes Federation
2. Dart A. B., Martens P. J., Rigatto C., Earlier onset of complications in youth with type 2 diabetes. Diabetes Care 2013 10.2337/dc13-0954
3. Khavandi K., Amer H., Ibrahim B., Strategies for preventing type 2 diabetes: an update for clinicians. Therapeutic Advances in Chronic Disease 2013 4 5 242 261
4. Cai L., Kang Y. J., Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovascular Toxicology 2001 1 3 181 193 2-s2.0-0035749812 10.1385/CT:1:3:181 (Pubitemid 37013746)
5. Miao X., Bai Y., Sun W., Sulforaphane prevention of diabetes-induced aortic damage was associated with the up-regulation of Nrf2 and its down-stream antioxidants. Nutrition & Metabolism 2012 9 1 84
6. Miao X., Wang Y., Sun J., Zinc protects against diabetes-induced pathogenic changes in the aorta: roles of metallothionein and nuclear factor (erythroid-derived 2)-like 2. Cardiovascular Diabetology 2013 12 54
7. Gupta S., Gambhir J. K., Kalra O., Association of biomarkers of inflammation and oxidative stress with the risk of chronic kidney disease in Type 2 diabetes mellitus in North Indian population. Journal of Diabetes and Its Complications 2013 27 6 548 552
8. King G. L., Loeken M. R., Hyperglycemia-induced oxidative stress in diabetic complications. Histochemistry and Cell Biology 2004 122 4 333 338 2-s2.0-8644267972 10.1007/s00418-004-0678-9 (Pubitemid 39506591)
9. Jeong I. K., King G. L., New perspectives on diabetic vascular complications: the loss of endogenous protective factors induced by hyperglycemia. Diabetes & Metabolism Journal 2011 35 1 8 11
10. Matough F. A., Budin S. B., Hamid Z. A., Alwahaibi N., Mohamed J., The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos University Medical Journal 2012 12 1 556 569 2-s2.0-84857082515
11. Cai L., Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications. Current Medicinal Chemistry 2007 14 20 2193 2203 2-s2.0-35348893135 10.2174/ 092986707781389646 (Pubitemid 47578157)
12. Lee J.-M., Johnson J. A., An important role of Nrf2-ARE pathway in the cellular defense mechanism. Journal of Biochemistry and Molecular Biology 2004 37 2 139 143 2-s2.0-2342514015 (Pubitemid 38608865)
13. Tkachev V. O., Menshchikova E. B., Zenkov N. K., Mechanism of the Nrf2/Keap1/ARE signaling system. Biochemistry 2011 76 4 407 422 2-s2.0-79958255513 10.1134/S0006297911040031
14. McMahon M., Itoh K., Yamamoto M., Hayes J. D., Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. Journal of Biological Chemistry 2003 278 24 21592 21600 2-s2.0-0037821802 10.1074/jbc.M300931200 (Pubitemid 36792558)
15. Thimmulappa R. K., Mai K. H., Srisuma S., Kensler T. W., Yamamoto M., Biswal S., Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Research 2002 62 18 5196 5203 2-s2.0-0037106099 (Pubitemid 35033454)
16. Li W., Kong A.-N., Molecular mechanisms of Nrf2-mediated antioxidant response. Molecular Carcinogenesis 2009 48 2 91 104 2-s2.0-59849113546 10.1002/mc.20465
17. Sykiotis G. P., Habeos I. G., Samuelson A. V., Bohmann D., The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation. Current Opinion in Clinical Nutrition and Metabolic Care 2011 14 1 41 48 2-s2.0-79851508187 10.1097/MCO.0b013e32834136f2
18. Donovan E. L., McCord J. M., Reuland D. J., Phytochemical activation of Nrf2 protects human coronary artery endothelial cells against an oxidative challenge. Oxidative Medicine and Cellular Longevity 2012 2012 9 132931 10.1155/2012/132931
19. Miao X., Cui W., Sun W., Therapeutic effect of MG132 on the aortic oxidative damage and inflammatory response in OVE26 type 1 diabetic mice. Oxidative Medicine and Cellular Longevity 2013 2013 12 879516 10.1155/2013/879516
20. Dinkova-Kostova A. T., Holtzclaw W. D., Cole R. N., Itoh K., Wakabayashi N., Katoh Y., Yamamoto M., Talalay P., Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proceedings of the National Academy of Sciences of the United States of America 2002 99 18 11908 11913 2-s2.0-0037015035 10.1073/pnas.172398899 (Pubitemid 34994497)
21. Keum Y.-S., Regulation of the Keap1/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modifications. Annals of the New York Academy of Sciences 2011 1229 1 184 189 2-s2.0-79960815640 10.1111/j.1749-6632.2011.06092.x
22. Guerrero-Beltrán C. E., Calderón-Oliver M., Pedraza-Chaverri J., Chirino Y. I., Protective effect of sulforaphane against oxidative stress: recent advances. Experimental and Toxicologic Pathology 2012 64 5 503 508 2-s2.0-84860447071 10.1016/j.etp.2010.11.005
23. Evans P. C., The influence of sulforaphane on vascular health and its relevance to nutritional approaches to prevent cardiovascular disease. EPMA Journal 2011 2 1 9 14 2-s2.0-79955656232 10.1007/s13167-011-0064-3
24. Fahey J. W., Talalay P., Antioxidant functions of sulforaphane: a potent inducer of phase II detoxication enzymes. Food and Chemical Toxicology 1999 37 9-10 973 979 2-s2.0-0032841203 10.1016/S0278-6915(99)00082-4 (Pubitemid 29481800)
25. Mu J., Woods J., Zhou Y.-P., Roy R. S., Li Z., Zycband E., Feng Y., Zhu L., Li C., Howard A. D., Moller D. E., Thornberry N. A., Zhang B. B., Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic β -cell mass and function in a rodent model of type 2 diabetes. Diabetes 2006 55 6 1695 1704 2-s2.0-33748331194 10.2337/db05-1602 (Pubitemid 44324122)
26. Zhao Y., Tan Y., Xi S., A novel mechanism by which SDF-1beta protects cardiac cells from palmitate-induced endoplasmic reticulum stress and apoptosis via CXCR7 and AMPK/p38 MAPK-mediated interleukin-6 generation. Diabetes 2013 62 7 2545 2558
27. Bai Y., Cui W., Xin Y., Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation. Journal of Molecular and Cellular Cardiology 2013 57C 82 95
28. Qazi A., Pal J., Maitah M., Fulciniti M., Pelluru D., Nanjappa P., Lee S., Batchu R. B., Prasad M., Bryant C. S., Rajput S., Gryaznov S., Beer D. G., Weaver D. W., Munshi N. C., Goyal R. K., Shammas M. A., Anticancer activity of a broccoli derivative, sulforaphane, in barrett adenocarcinoma: potential use in chemoprevention and as adjuvant in chemotherapy. Translational Oncology 2010 3 6 389 399 2-s2.0-78650323904 10.1593/tlo.10235
29. Mahéo K., Morel F., Langouët S., Kramer H., Le Ferrec E., Ketterer B., Guillouzo A., Inhibition of cytochromes P-450 and induction of glutathione S- transferases by sulforaphane in primary human and rat hepatocytes. Cancer Research 1997 57 17 3649 3652 2-s2.0-0030852501 (Pubitemid 27381200)
30. Simon D. I., Inflammation and vascular injury: basic discovery to drug development. Circulation Journal 2012 76 8 1811 1818
31. Ishigami N., Isoda K., Adachi T., Niida T., Kujiraoka T., Hakuno D., Kondo H., Kusuhara M., Ohsuzu F., Deficiency of CuZn superoxide dismutase promotes inflammation and alters medial structure following vascular injury. Journal of Atherosclerosis and Thrombosis 2011 18 11 1009 1017 2-s2.0-82455189550
32. Puntmann V. O., Taylor P. C., Mayr M., Coupling vascular and myocardial inflammatory injury into a common phenotype of cardiovascular dysfunction: systemic inflammation and aging-a mini-review. Gerontology 2011 57 4 295 303 2-s2.0-79959671348 10.1159/000316577
33. Davis C., Fischer J., Ley K., Sarembock I. J., The role of inflammation in vascular injury and repair. Journal of Thrombosis and Haemostasis 2003 1 8 1699 1709 2-s2.0-2142708560 10.1046/j.1538-7836.2003.00292.x
34. Palsamy P., Subramanian S., Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochimica et Biophysica Acta 2011 1812 7 719 731 2-s2.0-79955634116 10.1016/j.bbadis.2011.03.008
35. Tan Y., Ichikawa T., Li J., Si Q., Yang H., Chen X., Goldblatt C. S., Meyer C. J., Li X., Cai L., Cui T., Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes 2011 60 2 625 633 2-s2.0-79551575483 10.2337/db10-1164
36. Yang Y.-C., Lii C.-K., Lin A.-H., Yeh Y.-W., Yao H.-T., Li C.-C., Liu K.-L., Chen H.-W., Induction of glutathione synthesis and heme oxygenase 1 by the flavonoids butein and phloretin is mediated through the ERK/Nrf2 pathway and protects against oxidative stress. Free Radical Biology and Medicine 2011 51 11 2073 2081 2-s2.0-80255126225 10.1016/j.freeradbiomed.2011.09.007
37. Ungvari Z., Bailey-Downs L., Gautam T., Jimenez R., Losonczy G., Zhang C., Ballabh P., Recchia F. A., Wilkerson D. C., Sonntag W. E., Pearson K., de Cabo R., Csiszar A., Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia. American Journal of Physiology-Heart and Circulatory Physiology 2011 300 4 H1133 H1140 2-s2.0-79955068967 10.1152/ajpheart.00402.2010
38. Ishikado A., Morino K., Nishio Y., 4-Hydroxy hexenal derived from docosahexaenoic acid protects endothelial cells via Nrf2 activation. PloS One 2013 8 7 e69415
39. Avila P. R., Marques S. O., Luciano T. F., Resveratrol and fish oil reduce catecholamine-induced mortality in obese rats: role of oxidative stress in the myocardium and aorta. The British Journal of Nutrition 2013 110 9 1580 1590
40. He X., Kan H., Cai L., Ma Q., Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes. Journal of Molecular and Cellular Cardiology 2009 46 1 47 58 2-s2.0-57249104720 10.1016/j.yjmcc.2008.10. 007
41. Jiang T., Huang Z., Lin Y., Zhang Z., Fang D., Zhang D. D., The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy. Diabetes 2010 59 4 850 860 2-s2.0-77951199503 10.2337/db09-1342
42. De Haan J. B., Nrf2 activators as attractive therapeutics for diabetic nephropathy. Diabetes 2011 60 11 2683 2684 2-s2.0-80755168955 10.2337/db11-1072
43. Cui W., Li B., Bai Y., Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice. American Journal of Physiology 2013 304 1 E87 E99
44. Collins A. R., Lyon C. J., Xia X., Liu J. Z., Tangirala R. K., Yin F., Boyadjian R., Bikineyeva A., Praticò D., Harrison D. G., Hsueh W. A., Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circulation Research 2009 104 6 e42 e54 2-s2.0-64249150743 10.1161/CIRCRESAHA.108.188771